Market Tracker

04/26 4:55pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

95.30
Delayed Data
As of 4:00pm ET
 +0.97 / +1.03%
Today’s Change
51.33
Today|||52-Week Range
153.99
-24.99%
Year-to-Date

Today’s Trading

Previous close94.33
Today’s open95.34
Day’s range94.15 - 97.28
Volume607,730
Average volume (3 months)987,524
Market cap$13.3B
Data as of 4:00pm ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)-13.15%
Earnings growth (this year)-25.30%
Earnings growth (next 5 years)+163.00%
Revenue growth (last year)+90.66%
P/E ratioNM
Price/Sales127.96
Price/Book7.51

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc+1.98+4.49%
SGENSeattle Genetics Inc+0.73+1.52%
TSROTESARO Inc+0.33+0.64%
JAZZJazz Pharmaceuticals...-0.58-0.37%
Data as of 4:00pm ET, 04/26/2018

Financials

Next reporting dateMay 10, 2018
EPS forecast (this quarter)-$1.31
Annual revenue (last year)$89.9M
Annual profit (last year)-$490.9M
Net profit margin-545.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts